U.S. President Donald Trump promotes a recent reported decline in prescription drug prices, using a Washington Post headline about the “sharpest drop in more than 60 years.” The White House shares a photo-op image of Trump holding a printed copy of the article’s headline and discussing the figures with reporters. On social media, Trump and White House officials present the decline as evidence of his administration’s success.

Both reports describe the underlying Washington Post article as complicating Trump’s framing. The Post says independent experts believe the price drop is more likely linked to a policy introduced under President Joe Biden, rather than Trump’s actions. In particular, the experts point to Biden’s Inflation Reduction Act, which requires Medicare to negotiate prices for certain widely used prescription drugs, with the first negotiated reductions taking effect at the start of the year.

The outlets also note that experts question whether Trump’s policies are the main driver of the July decline, which is described in the coverage as a 3.1% year-over-year drop. The debate centers on attribution: Trump highlights the outcome, while cited experts emphasize the role of Biden-era negotiations.